Recently, Theron Pharmaceuticals 3 injections are expected to be approved.

Cylon Pharmaceuticals' upcoming product review status Agaquban is the world's first small molecule direct clotting enzyme inhibitor, which began in Japan in the early 1990s, and Agaquban can selectively bind to the catalytic site of clotting enzyme reversible, to achieve the effect of directly inhibiting clotting enzymes.
Aga Quban injection to study for Japan's Mitsubishi Pharmaceuticals, domestic enterprises have Tianjin Pharmaceutical Research Institute, the new era of pharmaceutical industry, Zhengda Tianqing. according to data from
- of-the-
-minnet.com, sales of Agaquban injections at the terminals of China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (referred to as China's public medical institutions) were 461 million yuan, up 24.42 percent year-on-year, with Tianjin Pharmaceutical Research Institute accounting for 99.74 percent of the market share.
the sales situation of Agaquban terminal of public medical institutions in China (units: 10,000 yuan) thymus method is a small molecule amino acid activity short peptide isolated from thymosin, with strong immune enhancement activity, can enhance the body's antiviral, anti-bacterial, anti-tumor immune activity, clinically used for the treatment of hepatitis B virus and hepatitis.
injection thymus method of xinyuan research for the United States Seisheng Pharmaceuticals, the domestic ownership of the variety of production approval of the enterprise has 12.
-meter net data show that in 2018, China's public medical institutions terminal injection thymus new sales of 2,908 million yuan, Seisheng Pharmaceuticals accounted for 50.58 percent of the market share, the proportion of the pharmaceutical industry of the o's nine-year-old medicine 20.78 percent.
new sales of terminal thymus method in public medical institutions in China (units: 10,000 yuan) for glycin as a paracetamol antimicrobial, through binding with the ribosome 30S subunits, to prevent ammonia tRNA molecules into the ribosome A, thereby inhibiting bacterial protein synthesis, to achieve antibacterial effect.
the injection of the original research for Pfizer Wyeth, the domestic ownership of the variety of production approval of the enterprise has seven.
Minet data show that in 2018, China's public medical institutions terminal injection of typendin sales of 2,061 million yuan, up 59.06 percent year-on-year, Pfizer accounted for 34.13 percent of the market share, Howson accounted for 33.62 percent.
China's public medical institutions terminal tyacycline sales (units: 10,000 yuan) data source: Minnet database original title: "Attention" 3 heavy injections, Cylon Pharmaceuticals is about to enter the bureau.